Design and Synthesis of an orally active GPIIb/IIIa antagonist based on a phenylpiperazine scaffold
- 1 June 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (12) , 1531-1536
- https://doi.org/10.1016/s0960-894x(98)00257-1
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Recent advances in cell adhesion molecules and extracellular matrix proteins: potential clinical implicationsDrug Discovery Today, 1997
- Orally Active Non-Peptide Fibrinogen Receptor (GpIIb/IIIa) Antagonists: Identification of 4-[4-[4-(Aminoimino methyl)phenyl]-1-piperazinyl]-1- piperidineacetic Acid as a Long-Acting, Broad-Spectrum Antithrombotic AgentJournal of Medicinal Chemistry, 1994
- Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptideJournal of the American Chemical Society, 1993
- Conformational analysis of 1‐arylpiperazines and 4‐arylpiperidinesRecueil des Travaux Chimiques des Pays-Bas, 1993
- Reversible conformational changes induced in glycoprotein IIb-IIIa by a potent and selective peptidomimetic inhibitorBlood, 1992
- Low molecular weight, non-peptide fibrinogen receptor antagonistsJournal of Medicinal Chemistry, 1992
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962